<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="139640">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01283126</url>
  </required_header>
  <id_info>
    <org_study_id>CHS #: 2010-09</org_study_id>
    <nct_id>NCT01283126</nct_id>
  </id_info>
  <brief_title>Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery</brief_title>
  <official_title>Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Joslin Diabetes Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Abbott Diabetes Care</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Joslin Diabetes Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to find out the effects of hypoglycemia on cognition in healthy
      individuals and how well changes in (interstitial) tissue glucose levels correlate with
      changes in cognitive function as compared to blood glucose levels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will undergo hypoglycemic clamps during which interstitial glucose will be measured
      and cognitive function will be assessed.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cognitive function correlation to blood or interstitial glucose</measure>
    <time_frame>1 year</time_frame>
    <description>This investigator initiated study will evaluate cognitive function at the onset, during and following recovery from hypoglycemia and will determine if cognitive function correlates better with blood or interstitial glucose concentrations.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Hypoglycemia</condition>
  <arm_group>
    <arm_group_label>Clamp</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will complete clamp study visit.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>euglycemic and hypoglycemic clamp</intervention_name>
    <description>Subjects will undergo standard euglycemic and hypoglycemic clamps, and will have concurrent assessments of cognitive function and measurement of interstitial glucose concentrations.</description>
    <arm_group_label>Clamp</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  non obese (BMI &lt;30), ages 18-50

        Exclusion Criteria:

          -  renal or hepatic failure

          -  cancer or lymphoma

          -  malabsorption or malnourishment

          -  hypercortisolism

          -  alcoholism or drug abuse

          -  anemia

          -  eating disorder or depression

          -  coronary artery disease

          -  Arrhythmias

          -  hypertension

          -  on medications known to affect the blood glucose to be measured such as

          -  glucocorticoids

          -  on blood thinning agents

               -  Pregnant women, breastfeeding women and women who want to become pregnant in the
                  next 6 months will be excluded from the study.

               -  Subjects who have donated blood two weeks prior to the study.

               -  Allergies to pig derived products (Heparin will be used)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Howard Wolpert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Joslin Diabetes Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Greeshma K Shetty, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Joslin Diabetes Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gail Musen, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Joslin Diabetes Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gail Adler, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Astrid Atakov Castillo, BA</last_name>
    <phone>617-309-1997</phone>
    <email>Astrid.Atakov-Castillo@joslin.harvard.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Joslin Diabetes Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Astrid Atakov Castillo, BA</last_name>
      <phone>617-309-1997</phone>
      <email>Astrid.Atakov-Castillo@joslin.harvard.edu</email>
    </contact>
    <contact_backup>
      <last_name>Shetty</last_name>
    </contact_backup>
    <investigator>
      <last_name>Howard Wolpert, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Greeshma K Shetty, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gail Musen, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gail Adler, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <lastchanged_date>September 20, 2014</lastchanged_date>
  <firstreceived_date>January 24, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Joslin Diabetes Center</investigator_affiliation>
    <investigator_full_name>Howard Wolpert</investigator_full_name>
    <investigator_title>Senior Physician, Joslin Diabetes Center; Director, Insulin Pump &amp; Continuous Glucose Monitoring Programs, Joslin Diabetes Center; Assistant Professor, Harvard Medical School</investigator_title>
  </responsible_party>
  <keyword>Hypoglycemia, cognitive function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypoglycemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypoglycemic Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
